| 摘要 |
medicine. SUBSTANCE: method deals with developing a composition for extracorporal treatment of biological liquids which contain magnetocontrolled sorbent and biocompatible liquid and, additionally, an anticoagulant at the following ratio of components: magnetocontrolled sorbent - 0.1-10.0; anticoagulant - 0.001-1.0; biocompatible liquid - the rest. At the same time magnetocontrolled sorbent contains a ferromagnetic nucleus covered with a single or double-layer membrane. EFFECT: higher efficiency of extracorporal treatment due to development of selective sorbent with target properties. 29 cl, 17 ex
|
